Home / Therapies / SGLT-2 Therapy Center (page 36)

SGLT-2 Therapy Center

Diabetes in Control is pleased to provide you with the latest insights and information on the Sodium-Dependent Glucose Transporter Two (SGLT-2) drug class to help optimize your practice. We hope you’ll benefit from the insights and share them with your colleagues. Thanks for all you’re doing to improve your patients’ lives and longevity!

EASD: Weight Loss with SGLT2 Inhibitors but More Infections

Three possible first in class drugs in the sodium glucose co-transporter (SGLT2 inhibitor) class showed improvements in glycemic control and weight loss, but infections proved troublesome, researchers reported…. Michael Nauck, MD, and colleagues of Diabeteszentrum Bad Lauterberg in Harz, Germany, looked at studies involving three investigational drugs in the sodium …

Read More »

Possible New Therapy for Type 2 Diabetes

Inhibitors Of The Novel Target Sodium-dependent Glucose (co-) Transporter (SGLT) For Therapy Of Type 2 Diabetes A plethora of SGLT inhibitors in the patent literature and seven compounds in early clinical development indicate an abundance of interest in the therapeutic use of SGLT inhibitors for the treatment of type 2 …

Read More »